MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI)*
Organization & Developments: Brainstorm Cell
Parents
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI)*
Children
2019: Reading Up On Brainstorm Cell Therapeutics_seekingalpha.com
2021: Brainstorm Cell Therapeutics: What's Left After Recent Trial Failure
2022: Not once, but twice: BrainStorm shares tumble as FDA again knocks back ALS drug
2023: BrainStorm Cuts 30% of Staff to Refocus on ALS Cell Therapy’s New Phase 3 Trial
It develops these therapies with its proprietary NurOwn platform.
It focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson’s disease, multiple sclerosis and spinal cord injury.
The company is focused on the development of central nervous system (CNS) adult stem cell therapies designed to address the unmet medical needs of patients with debilitating neurodegenerative diseases
Jumps
*Key People: Brainstorm Cell
Finance & Acquisitions: Brainstorm Cell